Jazz Pharmaceuticals plc (FRA:J7Z)

Jazz Pharmaceuticals Revenue

Jazz Pharmaceuticals had revenue of $1.13B USD in the quarter ending September 30, 2025, with 6.74% growth. This brings the company's revenue in the last twelve months to $4.16B, up 4.14% year-over-year. In the year 2024, Jazz Pharmaceuticals had annual revenue of $4.07B with 6.12% growth.

• Revenue (ttm): $4.16B
• Revenue Growth: +4.14%
• P/S Ratio: 2.54
• Revenue / Employee: $1.48M
• Employees: 2,800
• Market Cap: 9.00B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	4.07B	234.75M	6.12%
Dec 31, 2023	3.83B	174.83M	4.78%
Dec 31, 2022	3.66B	565.14M	18.26%
Dec 31, 2021	3.09B	730.67M	30.91%
Dec 31, 2020	2.36B	201.81M	9.34%
Dec 31, 2019	2.16B	270.84M	14.32%
Dec 31, 2018	1.89B	272.23M	16.82%
Dec 31, 2017	1.62B	130.72M	8.79%
Dec 31, 2016	1.49B	163.17M	12.32%
Dec 31, 2015	1.32B	151.93M	12.95%
Dec 31, 2014	1.17B	300.45M	34.44%
Dec 31, 2013	872.42M	286.44M	48.88%
Dec 31, 2012	585.98M	313.70M	115.21%
Dec 31, 2011	272.28M	98.50M	56.68%
Dec 31, 2010	173.78M	45.33M	35.29%
Dec 31, 2009	128.45M	60.94M	90.26%
Dec 31, 2008	67.51M	2.21M	3.39%
Dec 31, 2007	65.30M	20.45M	45.58%
Dec 31, 2006	44.86M	23.41M	109.20%
Dec 31, 2005	21.44M	-	-